Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Director/PDMR Shareholding

26 Jun 2012 15:15

RNS Number : 1838G
Consort Medical PLC
26 June 2012
Β 

ο»Ώ

Β 

Annex DTR3

Β 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

Β 

Β 

All relevant boxes should be completed in block capital letters.

Β 

1.

Name of the issuer

Β 

Β 

Consort Medical plc

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

Β 

I - DTR 3.1.2

3.

Name of person discharging managerial

responsibilities/director

Β 

Richard Cotton

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Β 

Β 

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1

Β 

The Notification is in respect of the Holdings of the persons referred to in 3 above.

Β 

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

N/A

Β 

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

Β 

N/A

Β 

8.

State the nature of the transaction

Β 

Β 

N/A

9.

Number of shares, debentures or financial

instruments relating to shares acquired

Β 

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

N/A

Β 

Β 

Β 

Β 

Β 

Β 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

Β 

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

Β 

13.

Price per share or value of transaction

Β 

N/A

Β 

14.

Date and place of transaction

Β 

N/A

Β 

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

N/A

Β 

16.

Date issuer informed of transaction

Β 

Β 

Β 

Β 

N/A

Β 

Β 

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

Β 

17.

Date of grant

Β 

Β 

25 June 2012

18.

Period during which or date on which exercisable

Β 

25 June 2015 to 4 August 2015 provided the applicable performance criteria have been satisfied.

Β 

19.

Total amount paid (if any) for grant of the option

Β 

NIL

20.

Description of shares or debentures involved (class and number)

Β 

Grant of Performance Shares under the Consort Medical 2005 Long Term Incentive Plan in respect of ordinary 10 pence shares as indicated in the table below:

Β 

Name

Status

Performance Shares Awarded

Richard Cotton

Director

40,581

Β 

Β 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

Β 

Β£6.53

Β 

22.

Total number of shares or debentures over which options held following notification including Deferred Bonus Awards

Β 

Please see table below:

Β 

Name

Status

Options Held

Richard Cotton

Director

40,581

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

23.

Any additional information

Β 

None

24.

Name of contact and telephone number for queries

Β 

John Slater - 01442 867920

Β 

Β 

Β 

Name of authorised official of issuer responsible for making notification - John Slater

Β 

Date of notification: 26 June 2012

Β 

Β 

Β 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

Β 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSZQLFLLQFFBBX
Date   Source Headline
1st Nov 20179:35 amRNSDirector/PDMR Shareholding
1st Nov 20179:04 amRNSTotal Voting Rights
16th Oct 20179:42 amRNSBlock listing Interim Review
11th Oct 20172:10 pmRNSDirector/PDMR Shareholding
11th Oct 201711:38 amRNSHolding(s) in Company
2nd Oct 201710:03 amRNSTotal Voting Rights
11th Sep 20175:15 pmRNSDirector/PDMR Shareholding
7th Sep 20171:56 pmRNSDirector/PDMR Shareholding
6th Sep 20174:35 pmRNSResult of AGM
1st Sep 20172:47 pmRNSDirector Declaration
10th Aug 20178:38 amRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
28th Jul 20173:48 pmRNSPosting of Annual Financial Report and AGM Notice
26th Jul 20179:22 amRNSDirector/PDMR Shareholding
20th Jul 20178:07 amRNSAdditional Listing
11th Jul 20178:53 amRNSDirector/PDMR Shareholding
21st Jun 201712:10 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
15th Jun 20177:00 amRNSFull year results
5th Jun 201710:09 amRNSDirector Declaration
8th May 20177:00 amRNSNotice of Results
2nd May 201711:10 amRNSTotal Voting Rights
27th Apr 201711:51 amRNSResult of General Meeting
18th Apr 20179:36 amRNSBlock listing Interim Review
3rd Apr 20179:49 amRNSNotice of GM
1st Mar 20179:22 amRNSTotal Voting Rights
30th Jan 201712:44 pmRNSHolding(s) in Company
26th Jan 20172:59 pmRNSHolding(s) in Company
23rd Jan 20177:00 amRNSParticipation in equity raise for Atlas Genetics
3rd Jan 20177:00 amRNSVoke® (DEV200) update
15th Dec 20169:45 amRNSHolding(s) in Company
14th Dec 201610:35 amRNSHolding(s) in Company
14th Dec 20167:00 amRNSDirectorate Change
9th Dec 20163:18 pmRNSDirector/PDMR Shareholding
6th Dec 20167:00 amRNSInterim Results
2nd Dec 20169:25 amRNSHolding(s) in Company
1st Dec 20169:43 amRNSTotal Voting Rights
25th Nov 20167:00 amRNSCFO Appointment
8th Nov 20161:24 pmRNSDirector/PDMR Shareholding
1st Nov 201610:15 amRNSTotal Voting Rights
31st Oct 20163:32 pmRNSDirector/PDMR Shareholding
31st Oct 20161:00 pmRNSNotice of Results
27th Oct 20167:00 amRNSCIMZIA® AutoClicks® prefilled pen launched in UK
14th Oct 201610:02 amRNSBlock listing Interim Review
14th Oct 20167:00 amRNSAnnouncement of master development agreement
11th Oct 201612:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20169:00 amRNSTotal Voting Rights
19th Sep 20169:47 amRNSBespak Technology in UCB PrefilledPen EMA Approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.